> Phase: Review  
> Work Unit / Run: WU-S2-006 / RV-S2-006-002  
> Role / Specialization: Reviewer / Independent review of Product/MVP source amendment checkpoint  
> Author: P-S2-006-RV-002-1 (KC-REVIEWER)  
> Created: 2026-10-02  
> Model / Reasoning: Invocation configured `gpt-6-luna` / `medium`; active runtime values not independently exposed  
> Session: fresh Participant context per Invocation; session identifier not exposed  
> Target revision: `7fd8b473b239b20bda3990ab29c51440d321a796` plus exact current diff for the two assigned Product/MVP files  
> Workflow revision: Harscode `pilot/orchestrator-v0.1@95ecf37ba8ae449a5b3b278c27331aca87360bc8`

## Review scope and identity

Reviewed only the current `HEAD` diff for `docs/product/mvp-scope.md` and `docs/product/mvp-delivery-slices.md`, as assigned. `HEAD` matches the invocation target revision. Current SHA-256 values match the Build checkpoint: `mvp-scope.md` `ba2972bc8f91d092e477df170d987b1d124964d9cc36c025d2a8da3ed12709af`; `mvp-delivery-slices.md` `4c69a030e7fedc9c62bf30f85c00e81f9806c45b2ed5471c1d5126762be8091f`. Other working-tree changes were excluded from this review.

The applicable execution contract is Approved Techplan `TP-S2-006-004`. Product/MVP authority resides in `docs/product/README.md`, `docs/product/mvp-scope.md`, and `docs/product/mvp-delivery-slices.md`; accepted direction and boundaries are also reflected in the Techplan and current parent event receipt.

## 1. Safety

No findings.

The amendment establishes product-level admission truth: settled Funding and the full amounts of accepted pending Donations count against finite Campaign capacity; pending failure adds no Funding and does not reopen the Campaign or replace the winning close reason. This is consistent with the approved Techplan's reservation and stable-close requirements. The Techplan Test Focus Pointer already carries the downstream concurrency, settlement, and close-ordering evidence obligations; no Techplan drift was found. No implementation/runtime claim is made by this source review.

## 2. Quality

No findings.

The wording is readable and keeps the donation limit, `max_amount` threshold, finite funding capacity, and Slice 3 public result behavior distinct. The same product rules are expressed at the appropriate resolutions in MVP scope and delivery sequencing without introducing endpoint, field, persistence, or mechanism detail owned by lower-level authorities.

## 3. Stack-Specific Best Practices

No relevant best-practice trigger matched this documentation-only Product/MVP amendment. The routed `best-practices/index.md` clue map was checked for relevant concerns; the diff introduces no implementation technology, runtime behavior, or technical mechanism requiring a stack-specific rule.

## 4. Consistency

No findings.

The changes fit the authority split in `docs/product/README.md`: `mvp-scope.md` owns approved release scope and `mvp-delivery-slices.md` owns approved delivery sequence, while concrete field names, contract shapes, database design, and implementation mechanisms remain downstream. The changes preserve the approved order and boundary: Slice 2 owns admission/eligibility and truthful pending settlement; Slice 3 owns the public closed-Campaign result. They also align with `docs/kencleng-agentic-workflow.md` routing and the Techplan's explicit D6 behavior (create omission default, PATCH omission preserve) without prematurely specifying those lower-level details in Product authority.

## Verification executed during Review

- Inspected the exact two-file diff against `HEAD`; confirmed `HEAD` equals the invocation target revision and current file hashes match the Build checkpoint. Result: scope identity confirmed.
- Read the Approved Techplan, canonical review guidance/checklist, applicable Product authority routing, and relevant Product/MVP sections. Result: no material contradiction found.
- No tests, validators, generators, runtime, browser, service, migration, race/load, or security suites were run; none were needed to resolve a source-review uncertainty and the Invocation excludes them.

## Verdict

**Approve** — the assigned Product/MVP source checkpoint faithfully expresses the approved direction and preserves the stated slice boundary. This technical review verdict is not Human Product/MVP acceptance and does not complete WU-S2-006.

## Phase handoff

- Completed: four-pass review + verdict.
- Artifacts: `.harscode-spaces/s2-guest-donation-truthful-state/WU-S2-006/runs/RV-S2-006-002/review-findings.md`.
- Human decision: accept or revise the concrete amendments in `docs/product/mvp-scope.md` and `docs/product/mvp-delivery-slices.md` as the owning Product/MVP authority.
- Open / deferred: Human source acceptance; remaining Campaign/Donation specification and authored API reconciliation, counterpart correspondence, and downstream delivery/runtime evidence remain open under the Approved Techplan.
- Recommended next step: route this satisfactory Product checkpoint to Human concrete source acceptance. After acceptance, resume the remaining approved source-reconciliation work through the Orchestrator. No patch plan is needed.
- Session transition: this independent Review occurrence ends here. Any later workflow re-entry uses a new Run and fresh Participant Session/context under orchestration rules.
- Context pointers: Approved `.harscode-spaces/s2-guest-donation-truthful-state/WU-S2-006/runs/TP-S2-006-004/techplan.md`; reviewed anchors are the two-file Product/MVP diff described above.
